developed αPD-1-IL-15-R, a fusion protein consisting of anti-PD-1 and IL-15-IL-15Rα, which showed remarkable antitumor efficacy without detectable toxicity across various kinds of tumor models. This evidence concerns the gene IL15RA and neoplasm.